These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15498350)

  • 1. [Expression of pRb and E2F-1 and telomerase activity in ameloblastoma].
    Zhong M; Wang J; Zhang B; Hou L; Yue YL; Li ZJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):406-9. PubMed ID: 15498350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of telomerase activity and cyclin A in ameloblastoma].
    Zhong M; Yue YL; Wang J; Wang ZY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jul; 38(4):257-60. PubMed ID: 12930651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma].
    Zhong M; Liu J; Gong YB; Liu JD; Wang J; Zhang B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):306-9. PubMed ID: 16191374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of human telomerase reverse transcriptase and bcl-2 in ameloblastoma].
    Wang J; Zhong M; Wang Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):441-3. PubMed ID: 14732976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of telomerase and p53 in ameloblastoma].
    Zhong M; Zhang LH; Wang J; Zhang B; Hou L
    Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
    Zeng XL; Tu ZG
    Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma].
    Zhong M; Yan Y; Wang J; Liu J; Li L; Gong YB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):304-7. PubMed ID: 17686286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of E2F-1 and Rb expression with papillomatosis and ductal carcinoma in situ of the breast].
    Niu Y; Li Y; Niu RF; Lü AJ; Fu XL
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):290-3. PubMed ID: 15312366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of the invasive biologic behavior of ameloblastoma].
    Zhong M; Li ZJ; Wang J; Yue YL; Bao G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):45-8. PubMed ID: 14989873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma].
    Zhong M; Li ZJ; Wang J; Zhang B; Hou L; Gong YB
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Dec; 22(6):499-502. PubMed ID: 15656532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
    Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
    Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
    Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
    J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity.
    Suenaga M; Yamaguchi A; Soda H; Orihara K; Tokito Y; Sakaki Y; Umehara M; Terashi K; Kawamata N; Oka M; Kohno S; Tei C
    Anticancer Res; 2006; 26(5A):3387-91. PubMed ID: 17094457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
    Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.